Carmignac Gestion’s SpringWorks Therapeutics SWTX Stock Holding History

Carmignac Gestion’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-148,806	Closed	-$6.99M	–	159
2025 Q2	$6.99M	Buy	+148,806	New	+$6.62M	0.11%	68

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Carmignac Gestion's SWTX Position: Q3 2025 in Review

Carmignac Gestion sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 148,806 shares — an estimated $6.99M sold.

Carmignac Gestion first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $6.99M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Carmignac Gestion reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Carmignac Gestion sold 148,806 SpringWorks Therapeutics shares in Q3 2025, an estimated $6.99M.
Carmignac Gestion first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
Carmignac Gestion's SpringWorks Therapeutics position peaked at $6.99M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Carmignac Gestion's 13F filing for Q3 2025, filed 13 Nov 2025.